LONDON--(BUSINESS WIRE)--Technavio has announced the top six leading vendors in the global consumer healthcare market in their latest research report. This report also highlights 38 other prominent vendors who are predicted to influence market growth over the forecast period.
To identify the top vendors, Technavio’s market research analysts have considered the top contributors to the overall revenue of this market. To calculate the market size, the report considers revenue generated from the sales of OTC pharmaceuticals and dietary supplements.
The report also covers the following regions:
- Americas: Focus is on the US, Canada, Mexico, and Brazil
- EMEA: Focus is on the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
- APAC: Focus is on Japan, China, Australia, Singapore, South Korea, and India
Request sample report: http://bit.ly/1RMJp0g
“The global consumer healthcare market is predicted to grow at a CAGR of 9.26% until 2020. OTC pharmaceuticals constitute a key segment of this market, and it is expected to witness high grow during the forecast period. The market is driven by an increased switch from prescription to OTC drugs. Further, increased awareness has accelerated self-medication practices, thereby boosting market growth. The developing economies of China, India, and Brazil are particularly expected to witness rapid growth owing to key government reforms and support in the form of investments over the forecast period,” said Barath Palada, one of Technavio’s lead analysts for cardiovascular and metabolic disorders.
“Owing to patent cliffs, many international companies are expected to enter the emerging markets to boost their market share by adopting optimum pricing strategies to make OTC products available at an affordable rate. International players such as Bayer, Novartis, and Sanofi have already made a mark in the market. The market is expected to witness new business ventures in the form of partnerships, acquisitions, and outsourcing until 2020,” added Barath.
Top six leading vendors in the global consumer healthcare market:
Johnson & Johnson
Johnson & Johnson, founded in 1887, is headquartered in New Brunswick, New Jersey, US. The company develops products across the infectious diseases, immunology, oncology, neuroscience, and metabolic and cardiovascular diseases therapy areas. They also develop and sell medical devices and consumer care products. The company recorded revenue of USD 74.33 billion in FY2014. The company’s consumer health segment covers products from skin care, baby care, oral care, women's health, wound care, and the OTC pharmaceuticals. The key consumer brands offered are Listerine, Clean & Clear, Neutrogena, Tylenol, Benadryl, Stayfree, and Band-Aid.
Bayer HealthCare
Bayer HealthCare, incorporated in 1863, is headquartered in Leverkusen, Germany. The company develops drugs, pharmaceuticals, vaccines, antibiotics, and small components for human and animal health worldwide. In FY2014, the company had 60,700 employees and spent USD 4.75 billion toward R&D. The company also generated revenue of close to USD 26.55 billion in the same fiscal year.
In FY2014, the consumer health segment reported a revenue of close to USD 10.53 billion, while the others (pharmaceuticals) segment reported a revenue of USD 16.02 billion. Bayer HealthCare has an established presence in the global consumer healthcare market with its range of offerings. In FY2014, the company spent close to USD 562.2 million on its consumer health segment.
GlaxoSmithKline
GlaxoSmithKline, founded in 2001, is headquartered in Brentford, England, UK. The company manufactures and markets pharmaceutical products, including OTC products, vaccines, and health-related consumer products worldwide. The company generated revenue of close to USD 37.9 billion and recorded R&D expenses worth USD 5.68 billion in FY2014. The company generates revenue through handheld software, handheld hardware, home console hardware, home console software, and other products.
GlaxoSmithKline's consumer healthcare segment manufactures and markets products for wellness, nutrition, skin health, and oral health. The key products offered are Sensodyne, Poligrip, Panadol, Parodontax, Thearflu, Voltaren, and Otrivin.
Sanofi
Sanofi, established in 1973, is headquartered in Paris, France. The company offers therapeutic solutions and healthcare products. In FY2014, the company generated close to USD 44.89 billion and spent around USD 6.41 billion on R&D.
Sanofi has an established presence in the global consumer healthcare market. In FY2014, the company reported revenue of close to USD 4.43 billion from the consumer healthcare category.
Pfizer
Pfizer, formed in 1849, is headquartered in New York, US. The company manufactures pharmaceutical products for the arthritis, cardiovascular, metabolic disorders, infectious, and respiratory therapeutic areas.
As of December 2014, the company had around 78,300 employees worldwide and reported net sales of close to USD 49.61 billion and spent around USD 8.39 billion on R&D. The consumer healthcare category of Pfizer is a part of the company's vaccines, oncology, and consumer healthcare (VOC) segment. The category reported a YoY increase of 5% in FY2014. The increase in revenue was due to the launch of Nexium 24HR in the US in May 2014 and the growth of vitamin supplement products in emerging markets.
Boehringer Ingelheim
Boehringer Ingelheim, established in 1885, is headquartered in Ingelheim am Rhein, Germany. The company manufactures pharmaceuticals, biomolecules, and chemicals worldwide. It manufactures pharmaceuticals for human and animal health. In FY2014, the company reported revenue of close to USD 17.7 billion and spent USD 3.52 billion on R&D.
Browse related reports:
- Global Healthcare SCM Market 2016-2020
- Global Healthcare Information Software Market 2015-2019
- Healthcare IT Market in Africa 2015-2019
- Healthcare IT Market in Turkey 2015-2019
Purchase three reports from our library for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact enquiry@technavio.com with your requirements and a link to our subscription platform.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
